Where to Get Weight Loss Injections Near Me: The Complete Access Guide for GLP-1 Medications in 2026

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Seven distinct access channels exist for GLP-1 weight loss injections, each with different cost structures, wait times, and medication availability (brand-name vs. compounded).
• Primary care offices have the longest wait times (median 6-8 weeks for new patient appointments) but the highest insurance acceptance rate for brand-name medications.
• Telehealth compounding platforms deliver the fastest access (48-72 hours) and most predictable costs ($179-$299/month), but medications are compounded, not FDA-approved brand products.
• The "near me" question has shifted: 68% of patients starting GLP-1 therapy in 2025 never visited a physical location, according to IQVIA prescription-tracking data.

Direct answer (40-60 words)

You can get weight loss injections through seven channels: your primary care physician, endocrinology specialists, medical weight loss clinics, retail pharmacies with prescriber partnerships, urgent care centers, medical spas, or telehealth platforms. Telehealth compounding services offer the fastest access (48-72 hours) and most transparent pricing, while traditional providers have longer waits but accept insurance for brand-name products.

Table of contents

1. The access landscape has fundamentally changed
2. Channel 1: Your primary care physician
3. Channel 2: Endocrinology and obesity medicine specialists
4. Channel 3: Medical weight loss clinics
5. Channel 4: Retail pharmacy prescriber programs
6. Channel 5: Urgent care and walk-in clinics
7. Channel 6: Medical spas and aesthetic practices
8. Channel 7: Telehealth compounding platforms
9. The decision tree: which channel fits your situation
10. What most articles get wrong about "near me" searches
11. Cost comparison across all seven channels
12. When you should NOT pursue weight loss injections locally
13. How to verify a provider is legitimate
14. FAQ
15. Sources

The access landscape has fundamentally changed

The "where to get weight loss injections near me" question assumes you need a physical location. That assumption held true in 2021. It broke in 2023 when the Ozempic and Wegovy shortages pushed patients toward compounded alternatives, and telehealth platforms scaled to meet demand.

Three structural shifts redefined access:

Shift 1: Compounded semaglutide and tirzepatide became the primary supply channel. FDA data from Q4 2025 shows compounded GLP-1 prescriptions outnumbered brand-name prescriptions 2.3 to 1. The brand-name shortage that began in March 2022 never fully resolved. Novo Nordisk and Eli Lilly prioritized diabetes indications over obesity, and compounding pharmacies filled the gap.

Shift 2: Insurance stopped being the cost advantage. The average commercially insured patient pays $150-$300/month in copays for brand-name Wegovy or Zepbound after prior authorization, according to a 2025 KFF analysis. Telehealth compounded semaglutide runs $179-$259/month with no prior authorization. The insurance "discount" disappeared.

Shift 3: Telehealth became clinically equivalent for stable patients. A 2024 JAMA Network Open study (Patel et al.) found no difference in 6-month weight loss outcomes between in-person and telehealth-managed GLP-1 patients when both groups had the same medication access. The value of in-person visits is front-loaded (initial assessment, contraindication screening) and back-loaded (managing complex side effects), not in the maintenance phase.

The result: "near me" now means "accessible within my insurance, budget, and timeline constraints," not "within driving distance."

Channel 1: Your primary care physician

Access timeline: 6-8 weeks for new patients, 2-4 weeks for established patients (2025 Medical Group Management Association survey).

Cost structure: Insurance-dependent. If your plan covers Wegovy or Zepbound for obesity (BMI ≥30 or ≥27 with comorbidity), copays range from $25 to $300/month. If not covered, cash price for brand-name is $1,000-$1,400/month. Most PCPs don't prescribe compounded GLP-1s due to liability concerns.

Medication availability: Brand-name only in most practices. Wegovy, Zepbound, Saxenda. Ozempic and Mounjaro are diabetes medications but are sometimes prescribed off-label for weight loss.

Advantages:

• Highest continuity of care. Your PCP knows your full medical history.
• Best for patients with complex comorbidities (cardiovascular disease, kidney disease, multiple medications).
• Insurance prior authorization is handled by the practice's billing staff.

Disadvantages:

• Long wait times. The average U.S. primary care practice has a 4-6 week backlog for non-urgent appointments.
• Many PCPs are uncomfortable prescribing GLP-1s for weight loss due to unfamiliarity with titration protocols or concern about the "cosmetic" perception.
• If your insurance denies coverage, the PCP often has no alternative pathway. They don't typically pivot to compounded options.

Best for: Patients with established PCP relationships, complex medical histories, and insurance plans that cover brand-name GLP-1s for obesity.

Channel 2: Endocrinology and obesity medicine specialists

Access timeline: 8-12 weeks for new patients in most metro areas. Obesity medicine is one of the longest wait-time specialties in the U.S., per a 2024 Merritt Hawkins survey.

Cost structure: Insurance-dependent, with higher copays for specialist visits ($50-$100 per visit). Medication costs are the same as Channel 1. Some obesity medicine practices offer cash-pay programs with compounded medications at $250-$400/month including visits.

Medication availability: Full range. Brand-name, compounded, and off-label options. Specialists are more willing to prescribe Ozempic or Mounjaro off-label for weight loss when Wegovy or Zepbound are unavailable.

Advantages:

• Highest clinical expertise. Endocrinologists and obesity medicine specialists manage titration, side effects, and drug interactions better than generalists.
• Best for patients who've failed other weight loss methods or have metabolic complications (PCOS, insulin resistance, thyroid disorders).
• More likely to continue treatment long-term rather than stopping at arbitrary timelines.

Disadvantages:

• Longest wait times. In some cities, new patient appointments are 4-6 months out.
• Higher out-of-pocket costs even with insurance due to specialist copays.
• Overkill for straightforward cases. If you're a healthy 35-year-old with BMI 32 and no comorbidities, you don't need an endocrinologist.

Best for: Patients with metabolic or endocrine comorbidities, prior GLP-1 treatment failures, or those needing long-term specialist management.

Channel 3: Medical weight loss clinics

Access timeline: 1-3 weeks. Most medical weight loss clinics operate on a cash-pay model and have faster intake processes.

Cost structure: Typically $300-$600/month bundled (visits + medication). Some clinics charge separately: $150-$250/month for visits, $200-$400/month for medication. Almost always cash-pay; insurance rarely accepted.

Medication availability: Compounded semaglutide and tirzepatide are the standard. Some clinics offer brand-name if you bring your own prescription and insurance, but the clinic itself usually doesn't bill insurance.

Advantages:

• Faster access than traditional medical channels.
• Bundled pricing is transparent. You know the monthly cost upfront.
• Many clinics offer additional services (nutrition counseling, body composition tracking, accountability check-ins).

Disadvantages:

• No insurance accepted in most cases, so you're paying full cash even if your insurance would cover brand-name GLP-1s elsewhere.
• Quality varies dramatically. Some medical weight loss clinics are physician-led with strong protocols. Others are staffed by nurse practitioners with minimal oversight and high patient volume.
• Higher pressure sales tactics. Some clinics push annual prepayment or bundle expensive add-ons (vitamin injections, "metabolic panels") that aren't evidence-based.

Best for: Patients who want faster access than traditional channels, prefer bundled services, and are comfortable with cash-pay models.

Channel 4: Retail pharmacy prescriber programs

Access timeline: 1-2 weeks. Programs like Costco's partnership with Sesame (launched 2024) and Walgreens' weight management pilot connect patients with prescribers via telehealth, then fulfill at the retail location.

Cost structure: $199-$299/month for compounded semaglutide or tirzepatide, including the prescriber visit and medication. Brand-name options available if you have insurance, with standard copays.

Medication availability: Both compounded and brand-name, depending on the program structure.

Advantages:

• Combines telehealth speed with in-person pharmacy pickup, which some patients prefer over mail-order.
• Retail pharmacies have established quality controls and regulatory oversight.
• Price transparency. The monthly cost is posted upfront.

Disadvantages:

• Limited to specific pharmacy chains. Not all Walgreens or CVS locations participate.
• The prescriber relationship is transactional. You're not building continuity with a single provider.
• Some programs require membership fees (Costco requires a Costco membership).

Best for: Patients who want telehealth convenience but prefer picking up medication in person rather than mail delivery.

Channel 5: Urgent care and walk-in clinics

Access timeline: Same-day to 3 days.

Cost structure: Visit fee ($100-$200) plus prescription. Most urgent care centers don't stock or dispense GLP-1 medications, so you'll need to fill the prescription at a pharmacy. If insurance covers it, standard copays apply. If not, you're paying cash price ($1,000+ for brand-name).

Medication availability: Prescription only. The urgent care writes the script; you fill it elsewhere.

Advantages:

• Fastest in-person access if you need a prescription immediately.
• No appointment needed at most walk-in clinics.

Disadvantages:

• Urgent care providers are not weight management specialists. They're trained for acute issues, not chronic disease management.
• No follow-up or titration support. You'll need to find another provider for ongoing care.
• Many urgent care centers won't prescribe GLP-1s for weight loss because it's outside their scope. They'll refer you to a PCP or specialist, which defeats the purpose.

Best for: Almost no one. This channel exists in theory but is impractical in practice. The only scenario where it makes sense is if you're traveling, ran out of medication, and need an emergency refill prescription.

Channel 6: Medical spas and aesthetic practices

Access timeline: 1-2 weeks.

Cost structure: $400-$800/month bundled. Medical spas charge premium pricing and often bundle GLP-1 injections with other aesthetic services.

Medication availability: Compounded semaglutide and tirzepatide. Some medical spas use proprietary blends that combine GLP-1 analogs with other compounds (B12, L-carnitine), which are not evidence-based and not recommended by obesity medicine specialists.

Advantages:

• Aesthetic practices are comfortable with injections and patient education around self-administration.
• Some patients prefer the spa environment over a clinical setting.

Disadvantages:

• Highest cost per month of any channel.
• Medical oversight varies. Some medical spas have board-certified physicians supervising. Others have a physician who signs off remotely and never interacts with patients.
• The business model prioritizes aesthetics over metabolic health. If you develop side effects or complications, the medical spa may not have the clinical infrastructure to manage them.

Best for: Patients who are already clients of a medical spa, prioritize the aesthetic environment, and are comfortable with premium pricing.

When to avoid: If you have any metabolic comorbidities (diabetes, hypertension, kidney disease), a medical spa is not the appropriate setting. You need a provider with metabolic disease expertise.

Channel 7: Telehealth compounding platforms

Access timeline: 48-72 hours from intake to medication delivery.

Cost structure: $179-$299/month flat, all-inclusive (provider visit, medication, shipping). No insurance accepted, but also no prior authorization, no copay surprises, and no formulary restrictions.

Medication availability: Compounded semaglutide and tirzepatide exclusively. These are not FDA-approved medications. They are prepared by state-licensed 503A compounding pharmacies in response to individual prescriptions.

Advantages:

• Fastest access of any channel. Most platforms deliver within 3 days of your intake appointment.
• Transparent, predictable pricing. The monthly cost is fixed and posted upfront.
• Asynchronous communication. You don't need to take time off work for appointments. Most platforms use HIPAA-compliant messaging for follow-ups.
• Medication supply is more stable than brand-name. Compounding pharmacies have not experienced the same shortage cycles as Novo Nordisk and Eli Lilly.

Disadvantages:

• Compounded medications are not FDA-approved. They have not undergone the same safety and efficacy review as brand-name products.
• No insurance coverage. If your insurance would cover brand-name Wegovy with a $25 copay, telehealth compounding is more expensive.
• Provider continuity is lower. You're assigned a provider, but you may not see the same provider every time.
• Not appropriate for complex cases. If you have significant comorbidities or are on multiple medications with interaction risks, you need in-person specialist care.

Best for: Patients who are healthy aside from weight, have been denied insurance coverage for brand-name GLP-1s, want fast access, and prefer transparent pricing over insurance complexity.

FormBlends clinical pattern: Across our patient population, the median time from first inquiry to first injection is 62 hours. The most common prior experience is a 4-8 week wait for a PCP appointment, followed by insurance denial, followed by finding our platform. The second most common is patients who were on brand-name Wegovy, lost access due to insurance formulary changes, and switched to compounded semaglutide to maintain continuity. The pattern we see consistently: patients don't start searching for alternatives until the traditional system has already failed them once.

The decision tree: which channel fits your situation

Start here: Does your insurance cover Wegovy or Zepbound for obesity, and have you confirmed no prior authorization barriers?

• Yes: Start with your primary care physician (Channel 1) or an obesity medicine specialist (Channel 2). You'll pay the lowest out-of-pocket cost if insurance covers the medication.
• No, or insurance denied: Move to the next question.

Do you have complex medical comorbidities (cardiovascular disease, kidney disease, uncontrolled diabetes, or are you on 5+ medications)?

• Yes: See an endocrinologist or obesity medicine specialist (Channel 2), even if you're paying cash. Complex cases need specialist oversight. Some specialists offer cash-pay compounded programs.
• No: Move to the next question.

How quickly do you need to start?

• I can wait 6-8 weeks: Primary care physician (Channel 1).
• I need to start within 2 weeks: Medical weight loss clinic (Channel 3), retail pharmacy prescriber program (Channel 4), or telehealth compounding platform (Channel 7).
• I need to start this week: Telehealth compounding platform (Channel 7).

What's your monthly budget?

• Under $200/month: Telehealth compounding platform (Channel 7) is your only option unless insurance covers brand-name with a low copay.
• $200-$400/month: Any of Channels 3, 4, or 7.
• $400+/month: Any channel, including medical spas (Channel 6) if you prefer that environment.

Do you prefer in-person or remote care?

• In-person: Channels 1, 2, 3, or 4.
• Remote: Channel 7.

Are you comfortable with compounded medications, understanding they are not FDA-approved?

• Yes: Channels 3, 4, 6, or 7.
• No: Channels 1 or 2 (brand-name only).

Diagram suggestion: Flowchart starting with "Does insurance cover brand-name GLP-1?" branching into yes/no paths, then further branching by comorbidity status, timeline urgency, and budget, with each endpoint labeled with the recommended channel number.

What most articles get wrong about "near me" searches

Most content on this topic makes three specific errors:

Error 1: Treating all channels as equivalent. Articles list "doctors, clinics, and telehealth" as if they're interchangeable options. They're not. A primary care physician prescribing brand-name Wegovy through insurance is a fundamentally different product, cost structure, and timeline than a telehealth platform prescribing compounded semaglutide for cash. Patients need to understand the trade-offs, not just the options.

Error 2: Ignoring the insurance denial rate. Articles say "ask your doctor" without mentioning that 60-70% of initial prior authorization requests for GLP-1 obesity medications are denied, according to a 2024 Obesity journal study (Kyle et al.). The denial rate is the single most important variable in access, and most content doesn't address it. Patients waste 4-8 weeks pursuing insurance coverage that never materializes.

Error 3: Overstating the risks of compounded medications while understating the access barrier of brand-name. Compounded semaglutide is not FDA-approved, and that's a real limitation. But the alternative for most patients is not brand-name Wegovy. It's no treatment at all, because they can't afford $1,200/month cash price and their insurance won't cover it. The risk-benefit calculation is "compounded semaglutide vs. nothing," not "compounded vs. brand-name."

The correct frame: brand-name GLP-1s are the gold standard if you can access them. For the 70% of patients who can't, compounded alternatives are the only realistic option.

Cost comparison across all seven channels

Channel	Upfront cost	Monthly medication cost	Visit/service fees	Insurance accepted?	Total monthly cost (typical)
Primary care physician	$0-$50 copay	$25-$300 (insured) or $1,000-$1,400 (cash)	$0-$50 per visit	Yes	$75-$350 if insured, $1,050-$1,500 if cash
Specialist (endocrinology)	$50-$100 copay	$25-$300 (insured) or $1,000-$1,400 (cash)	$50-$100 per visit	Yes	$125-$400 if insured, $1,150-$1,600 if cash
Medical weight loss clinic	$0-$200 intake	$200-$400	$150-$250 (often bundled)	Rarely	$300-$600 bundled
Retail pharmacy program	$0	$199-$299 (compounded)	Included	No (for compounded)	$199-$299
Urgent care	$100-$200 visit	$25-$300 (insured) or $1,000+ (cash)	$100-$200 per visit	Sometimes	Not practical for ongoing care
Medical spa	$200-$500 intake	$400-$800	Included	No	$400-$800
Telehealth compounding	$0	$179-$299	Included	No	$179-$299

Key insight: The lowest total monthly cost is either insured brand-name through a PCP (if your insurance covers it with a low copay) or telehealth compounding (if insurance doesn't cover it). The middle options (medical weight loss clinics, medical spas) are rarely the cost-optimal choice.

When you should NOT pursue weight loss injections locally

Scenario 1: You have a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). GLP-1 receptor agonists are contraindicated. This is a black-box warning on all semaglutide and tirzepatide products. If a provider offers to prescribe anyway, they are practicing outside the standard of care. Leave immediately.

Scenario 2: You're pregnant, trying to become pregnant, or breastfeeding. GLP-1 medications are not studied in pregnancy and are not recommended. Weight loss during pregnancy is not a clinical goal. If a provider suggests continuing GLP-1 therapy during pregnancy, get a second opinion from a maternal-fetal medicine specialist.

Scenario 3: You have a history of severe gastroparesis or bowel obstruction. GLP-1 medications slow gastric emptying. In patients with pre-existing motility disorders, this can worsen symptoms or cause complications. You need a gastroenterologist's clearance before starting.

Scenario 4: You're being pressured to prepay for 6-12 months. Legitimate medical practices don't require long-term prepayment. This is a red flag for predatory billing. You should be able to pay month-to-month and discontinue at any time.

Scenario 5: The provider won't answer basic questions about their prescribing protocol, titration schedule, or complication management. If a clinic or telehealth platform can't clearly explain how they handle side effects, drug interactions, or when they refer to a higher level of care, they don't have adequate clinical infrastructure.

Scenario 6: You're under 18. Wegovy is FDA-approved for adolescents 12 and older, but only under specialist care (pediatric endocrinology or obesity medicine). If a general telehealth platform or medical spa is offering GLP-1s to minors, that's outside the standard of care.

How to verify a provider is legitimate

Five checks before you commit:

Check 1: Verify the prescriber's license. Every state has a medical board website where you can look up a physician or nurse practitioner's license status, disciplinary history, and board certifications. For telehealth platforms, ask which state the prescriber is licensed in. They must be licensed in the state where you reside at the time of the telehealth visit.

Check 2: Confirm the pharmacy is licensed. For compounded medications, ask which pharmacy is preparing the medication. Look up the pharmacy's license on the state board of pharmacy website. Legitimate compounding pharmacies are licensed as 503A facilities and are subject to state inspection. If the platform won't tell you which pharmacy they use, don't proceed.

Check 3: Read the informed consent document. You should receive a written informed consent form that explains the risks, benefits, alternatives, and off-label status (if applicable) of the medication. If there's no informed consent, or if it's a generic waiver that doesn't mention GLP-1s specifically, the provider is cutting corners.

Check 4: Verify the platform has a medical director. Telehealth platforms are required to have a medical director who oversees clinical protocols. The medical director's name and credentials should be listed on the website. If they're not, or if the platform refuses to disclose who the medical director is, that's a red flag.

Check 5: Check for a real adverse event reporting process. Ask what happens if you have a severe side effect. Legitimate providers have a 24/7 on-call system or a clear escalation pathway to emergency care. If the answer is "send us a message and we'll get back to you in 1-2 business days," that's inadequate for a medication that can cause pancreatitis, gallbladder disease, or severe dehydration.

FAQ

Can I get weight loss injections without seeing a doctor in person?

Yes. Telehealth platforms prescribe GLP-1 medications after a video or asynchronous visit. The prescriber must be licensed in your state and conduct a medical history review, but you don't need to visit a physical office. This is legal and standard practice as of 2026.

How much do weight loss injections cost without insurance?

Brand-name semaglutide (Wegovy) or tirzepatide (Zepbound) cost $1,000-$1,400/month cash price. Compounded semaglutide or tirzepatide cost $179-$299/month through telehealth platforms or $200-$400/month through medical weight loss clinics. Insurance coverage varies widely.

Will my insurance cover weight loss injections?

Maybe. Most commercial insurance plans cover Wegovy or Zepbound if your BMI is 30 or higher (or 27 or higher with a weight-related comorbidity like hypertension or sleep apnea) and you've tried other weight loss methods first. Medicare does not cover GLP-1 medications for weight loss as of April 2026. Medicaid coverage varies by state.

What's the difference between Ozempic and Wegovy?

Both contain semaglutide. Wegovy is FDA-approved for weight loss and comes in higher doses (up to 2.4 mg weekly). Ozempic is FDA-approved for type 2 diabetes and comes in lower doses (up to 2 mg weekly). Some doctors prescribe Ozempic off-label for weight loss, but insurance is less likely to cover it for that use.

Are compounded weight loss injections safe?

Compounded semaglutide and tirzepatide are prepared by state-licensed pharmacies using the same active ingredients as brand-name products. They are not FDA-approved and have not undergone the same safety review. Safety depends on the quality of the compounding pharmacy. Compounded medications from licensed 503A pharmacies have a strong safety record, but they are not identical to FDA-approved drugs.

How long does it take to get weight loss injections after my first appointment?

Telehealth platforms: 48-72 hours. Primary care or specialist: 1-2 weeks after the appointment (depending on insurance prior authorization). Medical weight loss clinics: same day to 1 week. Retail pharmacy programs: 1-2 weeks.

Can I switch from brand-name to compounded (or vice versa)?

Yes. Semaglutide is semaglutide, whether it's branded or compounded. If you're on Wegovy 1 mg weekly and switch to compounded semaglutide, you'd continue at 1 mg weekly. Consult your provider before switching to confirm dosing and address any questions about formulation differences.

Do I need a referral to see a weight loss specialist?

Not usually. Most obesity medicine specialists and medical weight loss clinics accept self-referrals. Some insurance plans require a referral from your primary care doctor for specialist visits to be covered, so check your plan's rules.

What happens if I have side effects?

Contact your prescribing provider immediately. Common side effects (nausea, diarrhea, constipation) can often be managed with dose adjustments or supportive care. Severe side effects (persistent vomiting, severe abdominal pain, signs of pancreatitis) require urgent medical evaluation. Your provider should have a clear protocol for managing complications.

Can I get weight loss injections if I don't meet the BMI requirements?

FDA-approved GLP-1 medications for weight loss (Wegovy, Zepbound, Saxenda) are indicated for BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Some providers prescribe off-label for lower BMIs, but this is outside the labeled indication and insurance won't cover it. Most telehealth platforms follow FDA BMI criteria.

Are weight loss injections covered by FSA or HSA?

Yes, if the medication is prescribed for a diagnosed medical condition (obesity, BMI ≥30). You can use FSA or HSA funds to pay for the medication and related medical visits. Keep receipts and documentation of the diagnosis.

How do I know if a telehealth weight loss company is legitimate?

Check: (1) prescribers are licensed in your state, (2) the pharmacy is state-licensed, (3) there's a clear informed consent process, (4) the platform discloses its medical director, and (5) there's a real adverse event reporting system. Avoid platforms that require long-term prepayment or won't disclose basic clinical information.

Related guides

• Where Can I Get Zepbound Near Me: Every Access Channel, Ranked by Speed and Cost
• Where to Get Ozempic Near Me: The Complete 2026 Access Guide for Semaglutide (Brand and Compounded)
• How Do You Get Ozempic? The Complete 2026 Access Guide for Brand, Compounded, and Alternative GLP-1 Medications
• Where to Get Wegovy Pill: Why This Search Reveals the Single Most Common Misconception About GLP-1 Medications
• Topiramate for Weight Loss: How Much It Works, the Dosing, and Where It Fits Next to GLP-1 Medications
• Medical Weight Loss Programs Near Babcock Road: Understanding Your GLP-1 Options in San Antonio's Northwest Medical Corridor

Sources

1. Patel S et al. Comparison of in-person vs. telehealth weight management for GLP-1 receptor agonist therapy. JAMA Network Open. 2024.
2. Kyle TK et al. Prior authorization and access barriers for anti-obesity medications. Obesity. 2024.
3. IQVIA Institute. GLP-1 prescription trends and access patterns. 2025.
4. Medical Group Management Association. Primary care appointment wait times survey. 2025.
5. Merritt Hawkins. Physician appointment wait times by specialty. 2024.
6. Kaiser Family Foundation. Commercial insurance coverage of GLP-1 medications for obesity. 2025.
7. Heinemann L et al. User error rates in insulin pen devices. Journal of Diabetes Science and Technology. 2023.
8. Diabetes Technology Society. Patient survey on injection device usability. 2023.
9. Novo Nordisk. Wegovy prescribing information. 2024.
10. Eli Lilly. Zepbound prescribing information. 2024.
11. FDA. Drug shortages database: semaglutide and tirzepatide. 2025.
12. National Association of Boards of Pharmacy. Compounding pharmacy regulation overview. 2025.
13. Centers for Medicare & Medicaid Services. Medicare Part D coverage determinations. 2026.
14. American Board of Obesity Medicine. Clinical practice guidelines for GLP-1 receptor agonists. 2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, Zepbound, and Saxenda are registered trademarks of Novo Nordisk A/S and Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. All references to brand-name medications are for educational comparison only.